Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Diehm

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
VASA. Supplementum|January 1, 1992
[An epidemiologic study of the value and limits of physical therapy/exercise therapy in Fontaine stage II arterial occlusive disease]R de la Haye, C Diehm, J Blume, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1993
[Comparison between argon and excimer laser angioplasty in patients with lesions of the femoral and popliteal arteries: clinical and angiography results after 1 year]C Wilhelm, A Schömig, J Brachmann, et al.
VASA. Supplementum|January 1, 1991
[An epidemiologic study of the use of vascular sports in arterial occlusive disease]R de la Haye, C Diehm, J Blume, et al.
VASA. Supplementum|January 1, 1989
[Effect of prostaglandin E1 on function and deformability of neutrophilic granulocytes in patients with stage IV peripheral arterial occlusive disease]F J Neumann, C Diehm, U Müller-Bühl, et al.
Prostaglandins|March 1, 1991
Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive diseaseB A Peskar, W H Hesse, W Rogatti, et al.
Circulation|September 1, 1990
Activation and decreased deformability of neutrophils after intermittent claudicationF J Neumann, W Waas, C Diehm, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
[Development of an illness-specific instrument for assessment of quality of life in patients with arterial occlusive disease (Peripheral Arterial Occlusive Disease 86 Questionnaire)]M Bullinger, M Cachovan, A Creutzig, et al.
VASA. Supplementum|January 1, 1991
[Angioscintigraphy with krypton 81 m, a semiquantitative method for measuring tissue perfusion in patients with arterial occlusive disorders]K Amendt, G Köstlin, J Adrian, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 15, 1995
[Quality of life in peripheral arterial occlusive disease. Multicenter study of quality of life characteristics with a newly developed disease-specific questionnaire]H Heidrich, M Bullinger, M Cachovan, et al.
VASA. Supplementum|January 1, 1991
[Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease]W Hepp, S von Bary, D Corovic, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
VASA. Supplementum|January 1, 1992
[An epidemiologic study of the value and limits of physical therapy/exercise therapy in Fontaine stage II arterial occlusive disease]R de la Haye, C Diehm, J Blume, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1993
[Comparison between argon and excimer laser angioplasty in patients with lesions of the femoral and popliteal arteries: clinical and angiography results after 1 year]C Wilhelm, A Schömig, J Brachmann, et al.
VASA. Supplementum|January 1, 1991
[An epidemiologic study of the use of vascular sports in arterial occlusive disease]R de la Haye, C Diehm, J Blume, et al.
VASA. Supplementum|January 1, 1989
[Effect of prostaglandin E1 on function and deformability of neutrophilic granulocytes in patients with stage IV peripheral arterial occlusive disease]F J Neumann, C Diehm, U Müller-Bühl, et al.
Prostaglandins|March 1, 1991
Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive diseaseB A Peskar, W H Hesse, W Rogatti, et al.
Circulation|September 1, 1990
Activation and decreased deformability of neutrophils after intermittent claudicationF J Neumann, W Waas, C Diehm, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
[Development of an illness-specific instrument for assessment of quality of life in patients with arterial occlusive disease (Peripheral Arterial Occlusive Disease 86 Questionnaire)]M Bullinger, M Cachovan, A Creutzig, et al.
VASA. Supplementum|January 1, 1991
[Angioscintigraphy with krypton 81 m, a semiquantitative method for measuring tissue perfusion in patients with arterial occlusive disorders]K Amendt, G Köstlin, J Adrian, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 15, 1995
[Quality of life in peripheral arterial occlusive disease. Multicenter study of quality of life characteristics with a newly developed disease-specific questionnaire]H Heidrich, M Bullinger, M Cachovan, et al.
VASA. Supplementum|January 1, 1991
[Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease]W Hepp, S von Bary, D Corovic, et al.
Pageof 17